EXCLUSIVE: NewcelX Advances Diabetes Therapy Toward Human Trials With FDA Pre-IND Submission
Eledon Pharmaceuticals Inc ELDN
$3.84
▼ -1.54%
($-0.06)
Open
$3.89
Prev Close
$3.90
Day Range
$3.77 – $3.89
52W Range
$1.35 – $4.60
Market Cap
$292.16M
Beta
1.01
EPS (TTM)
$-0.83
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2014-09-17 |
| Shares Out. | 77,190,000 |
| Website | eledon.com/ ↗ |
| Phone | 13025814070 |
Eledon Pharmaceuticals Inc is a publicly traded company under the ticker symbol ELDN on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
13 analysts (2026-05-01)